|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 G STREET, NW |
Address2 | SUITE 900 EAST |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 31680-226
|
||||||||
|
6. House ID# 311100006
|
TYPE OF REPORT | 8. Year | 2007 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Kimberley Fritts, CEO |
Date | 09/16/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S. 1145, Patent Reform Act of 2007, entire bill
H. R. 1908, Patent Reform Act of 2007, entire bill
17. House(s) of Congress and Federal agencies Check if None
Y Y Patent and Trademark Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Anthony |
Podesta |
|
|
|
Seth |
Nichols |
|
|
|
Anne Marie |
Polak |
|
Leg Correspondent for Cong. Mike Ferguson |
|
Paul |
Brathwaite |
|
Exec Dir, Congressional Black Caucus 22 Mem |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
SCHIP (Senate), Medicare cuts to finance SCHIP expansion
H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
17. House(s) of Congress and Federal agencies Check if None
Y Y CMS Department of Health and Human Services Executive Office of the President
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Seth |
Nichols |
|
|
|
Anthony |
Podesta |
|
|
|
Andrew |
Kauders |
|
Sr Adv, Sen. Menendez; ED, House Dem Caucus |
|
Anne Marie |
Polak |
|
Leg Correspondent for Cong. Mike Ferguson |
|
Heather |
Urban |
|
Leg Dir, Sen. H. Reid; Leg Dir Cong. S. Berkley |
|
Paul |
Brathwaite |
|
Exec Dir, Congressional Black Caucus 22 Mem |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
SCHIP (Senate), Medicare cuts to finance SCHIP expansion
H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
S. 623, Access to Life-Saving Medicine Act, follow-on biologics
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics
H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics
S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics
S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics
H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions
S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions
H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions
S. 467, FACT Act, clinical trials/drug safety provisions
S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions
S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions
S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions
S. 1024, Safer DATA Act, clinical trials/drug safety provisions
H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions
S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
17. House(s) of Congress and Federal agencies Check if None
Y Y Department of Health and Human Services Executive Office of the President Food and Drug Administration
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Elizabeth |
Morra |
|
|
|
Seth |
Nichols |
|
|
|
Anthony |
Podesta |
|
|
|
Courtney |
Hagen |
|
|
|
Andrew |
Kauders |
|
Sr Adv, Sen. Menendez; ED, House Dem Caucus |
|
Anne Marie |
Polak |
|
Leg Correspondent for Cong. Mike Ferguson |
|
Heather |
Urban |
|
Leg Dir, Sen. H. Reid; Leg Dir Cong. S. Berkley |
|
Paul |
Brathwaite |
|
Exec Dir, Congressional Black Caucus 22 Mem |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions
H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions
H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions
S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions
17. House(s) of Congress and Federal agencies Check if None
Y Y
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Anne Marie |
Polak |
|
Leg Correspondent for Cong. Mike Ferguson |
|
Anthony |
Podesta |
|
|
|
Heather |
Urban |
|
Leg Dir, Sen. H. Reid; Leg Dir Cong. S. Berkley |
|
Paul |
Brathwaite |
|
Exec Dir, Congressional Black Caucus 22 Mem |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions
H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions
17. House(s) of Congress and Federal agencies Check if None
Y Y
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Anne Marie |
Polak |
|
Leg Correspondent for Cong. Mike Ferguson |
|
Heather |
Urban |
|
Leg Dir, Sen. H. Reid; Leg Dir Cong. S. Berkley |
|
Paul |
Brathwaite |
|
Exec Dir, Congressional Black Caucus 22 Mem |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TAX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |